Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma
Clinical trial NCT01441973 · COMPLETED
Trial details
- NCT number
- NCT01441973
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-28
- Primary completion
- 2014-05-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.